4.0 Article

Metabotropic Glutamate Receptor 2 and Corticotrophin-Releasing Factor Receptor-1 Gene Expression is Differently Regulated by BDNF in Rat Primary Cortical Neurons

期刊

SYNAPSE
卷 67, 期 11, 页码 794-800

出版社

WILEY
DOI: 10.1002/syn.21689

关键词

metabotropic glutamate receptor 2 (mGluR2); corticotrophin-releasing factor receptor-1 (CRF-R1); synapse; serotonin receptor 2A (5-HT2AR); receptor regulation

资金

  1. Lundbeck Foundation
  2. Rigshospitalets Forskningsfond
  3. Danish Council for Strategic Research (The Programme Commission on Individuals, Disease and Society) (Cognito)

向作者/读者索取更多资源

Brain-derived neurotrophic factor (BDNF) is important for neuronal survival and plasticity. Incorporation of matured receptor proteins is an integral part of synapse formation. However, whether BDNF increases synthesis and integration of receptors in functional synapses directly is unclear. We are particularly interested in the regulation of the 5-hydroxytryptamine receptor 2A (5-HT2AR). This receptor form a functional complex with the metabotropic glutamate receptor 2 (mGluR2) and is recruited to the cell membrane by the corticotrophin-releasing factor receptor 1 (CRF-R1). The effect of BDNF on gene expression for all these receptors, as well as a number of immediate-early genes, was pharmacologically characterized in primary neurons from rat frontal cortex. BDNF increased CRF-R1 mRNA levels up to fivefold, whereas mGluR2 mRNA levels were proportionally downregulated. No effect on 5-HT2AR mRNA was seen. The effects were dose-dependent with half-maximal effective concentrations (EC50) around 1 ng/ml. After 24 h of incubation with BDNF, CRF-R1 mRNA levels had returned to baseline levels, whereas mGluR2 mRNA levels remained low. A significant reduction of all three receptor transcripts was observed after neuronal depolarization produced by high potassium. This study emphasizes the role of BDNF as an important regulator of receptor compositions in the synapse and provides further evidence that BDNF directly regulates important drug targets involved in cognition and mood. Synapse 67:794-800, 2013.. (c) 2013 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据